Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Tata Mid Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹104.21 |
| 12 Apr 2015 | ₹220.99 |
| 31 May 2016 | ₹203.77 |
| 19 Jul 2017 | ₹275.40 |
| 07 Sep 2018 | ₹289.94 |
| 27 Oct 2019 | ₹294.39 |
| 15 Dec 2020 | ₹373.90 |
| 03 Feb 2022 | ₹538.90 |
| 25 Mar 2023 | ₹525.57 |
| 12 May 2024 | ₹862.75 |
| 01 Jul 2025 | ₹1000.59 |
| 20 Aug 2026 | ₹1090.66 |
| Metric | Tata · Direct NAV ₹539.97 Very High risk ★★☆☆☆ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +9.84% | +9.87% | |
| +17.49% | +19.74% | |
| +16.89% | +17.84% | |
| +17.01% | +17.01% | |
| +19.16% | +19.29% | |
| +16.97% | — | |
| +19.74% | +20.53% | |
| +18.69% | +19.07% | |
| +19.05% | +18.49% | |
| Risk | ||
| 15.59% | 16.20% | |
| 0.70 | 0.83 | |
| 0.94 | 1.14 | |
| -35.10% | -32.95% | |
| Nifty Midcap 150 | — | |
| +0.68% | +2.33% | |
| 0.89 | 0.94 | |
| 89.2% | 98.4% | |
| 81.2% | 87.8% | |
| 0.87% | 0.97% | |
| ₹5,650Cr | ₹7,594Cr | |
| 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 47% | 40% | |
| Satish Chandra Mishra · 5.5y | — | |
| 02 Jan 2013 | — | |
| 65 | — | |
| 28.0% | — | |
| 0.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.